Amsterdam institute for Immunology and Infectious diseases
Valorization Committee
The AI&I Valorization Committee
The AI&I Valorization Committee consists of a diverse group of members, including principal investigators, postdocs, PhD students, and members of the Business Development team. This broad composition ensures a good balance between junior and senior researchers, as well as between fundamental research and clinical practice.
The committee develops plans and organizes activities within a framework set by the AI&I Board, ensuring alignment with AI&I’s overall vision and objectives, as well as with the individual research programs. Its main focus is on strengthening valorization, optimizing the role of Dedicated Business Developers, promoting public-private collaborations, and enhancing visibility and knowledge sharing.
The committee also plays an active role in the Amsterdam Valorization Board (AVB), representing AI&I and helping to shape new directions in valorization.
Committee members
Chair: Prof. dr. Conny van der Laken
Committee members: Prof. dr. Rosalie Luiten, Dilek Yusuf, Dr. Gijs Kooij, Dr. Oliver Chen and Kathelijn Verdeyen
Business Development team
The AI&I Business Development team supports researchers in generating societal and economic impact. Serving as a dedicated point of contact for AI&I and working closely with Innovation Exchange Amsterdam (IXA), the team provides guidance on valorization, collaborations with private partners, intellectual property, and impact strategies.
More information about the Business Development team can be found he here
Learn more about our Business Development team in this article.
You can reach out to your dedicated business developer directly or contact the general emailaddress (ixa_aii@amsterdamumc.nl).